Navigation Links
Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
Date:10/18/2010

BEND, Ore., Oct. 18 /PRNewswire/ -- Bend Research Inc. (www.bendres.com), a leading independent technology-based drug-formulation development and manufacturing organization, announced today it has extended its drug discovery enablement and development services agreement with Bristol-Myers Squibb Company (www.bms.com) (NYSE: BMY), a global biopharmaceutical company.

Under the terms of the 3-year agreement, Bristol-Myers Squibb will use Bend Research's formulation development and manufacturing services for preclinical and clinical development. Bend Research will also manufacture drug product intermediates and drug products in its current Good Manufacturing Practice (cGMP) facility for Bristol-Myers Squibb clinical trials.

In the collaboration, the two companies will use their complementary fundamental scientific capabilities to solve complex formulation and process-development challenges.

"We are very excited to extend our working agreement with Bristol-Myers Squibb and to combine the knowledge and experience of our two companies," said Rod Ray, Bend Research CEO. "We share a commitment to applying fundamental science and engineering to the delivery of new medicines that will enhance patients' lives. We look forward to a long and successful relationship."

As part of the collaboration, Bend Research is making its proprietary spray-dried dispersion (SDD) technology available to Bristol-Myers Squibb. This technology has been successfully applied to hundreds of compounds at various phases of development, from preclinical studies to Phase 3 clinical trials.

Since late 2008, Bend Research has rapidly expanded its roster of clients by making its multidisciplinary approach available to companies trying to solve difficult formulation and development problems. The company's flexible cl
'/>"/>

SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
2. Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
3. New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
4. Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies
5. CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
6. Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
7. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
8. Cellectis bioresearch Announces Establishment of Subsidiary in the US
9. Vaccine and Medication Safety are Parents Top Research Priorities
10. VNSNY Uses Advanced Technology to Assess In-Home Performance of Nurses and Incorporate New Medical Research to Improve Patient Care
11. Varian Medical Systems and Stanford University Win $3.6 Million Five-Year NIH/NCI Research Grant to Develop Advanced Imaging Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  Surgical Theater, LLC announced today the ... Advisory Board. New members include Ori J. ... Development and New Technologies for Given Imaging Ltd., ... Vice President and General Manager of Philips Healthcare,s ... simulation technology to brain surgery and has developed ...
(Date:7/28/2014)...  VigeneTech, Inc, in collaboration with BioLegend, Inc., ... Software, an OEM software solution for analysis of ... offers varieties of bead-based multi-analyte immunoassay products for ... VigeneTech,s data analysis software, FCS data files can ... LEGENDplex™ software is a robust ...
(Date:7/28/2014)... , July 28, 2014  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Tuesday, ... Officer and Michael Carruthers , Chief ... InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) ...
Breaking Medicine Technology:Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... THOUSAND OAKS, Calif., Nov. 5, 2011 Amgen ... the first three years of the open-label extension study of ... of Prolia® (denosumab) treatment in postmenopausal women with osteoporosis was ... consistent reduction in markers of bone turnover. These results will ...
... Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) ... analysis of PILLAR, a phase 2b study of the ... in treatment-naive patients with chronic genotype 1 HCV, as ... Annual Meeting of the American Association for the Study ...
Cached Medicine Technology:Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 2Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 3Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 4Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 5Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 6Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 7Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 8Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 9Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD 2Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD 3Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD 4
(Date:7/29/2014)... July 29, 2014 Current Back2Basics long-term ... pain medication post foot surgery during his first six months ... foot surgery – twice on one foot, once on the ... “I broke my foot a year ago and was prescribed ... to Jon by a friend from home who’d recently completed ...
(Date:7/29/2014)... Consilium Staffing, Your Partner in Locum Tenens, ... point of 2014, with strong indications the Irving, Texas-based firm ... this year. , “This is a great time to be ... Staffing. , “We are proud of what we have ... are even more excited about how things are shaping up ...
(Date:7/29/2014)... July 29, 2014 In today’s world, a ... to get. Snoring and sleep apnea (a medical problem where ... and their bed partners of the rest they need to ... the population snores and 20 million people in the United ... been diagnosed and treated; and of those treated, many cannot ...
(Date:7/29/2014)... latest blog post at http://www.perwickstrom.com , entrepreneur, author, speaker ... ways to light the “fire” in employees. , “Employers are ... some it’s a losing battle,” commented Per Wickstrom . ... employees get to the next level; which not only helps ... Per Wickstrom, 6 ways to light the “fire” in employees ...
(Date:7/29/2014)... Angeles, CA (PRWEB) July 29, 2014 ... of 3.1 out of 5. This score reflects a ... result of the large number of suppliers, the product's ... tank market, says IBISWorld analyst Jordan Weinstein. IBISWorld estimates ... buyers with a substantial number of supplier options. However, ...
Breaking Medicine News(10 mins):Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:Consilium Staffing Experiences Significant Revenue Growth 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4
... COLUMBIA, Mo. Nursing is among construction and law ... on-the-job injuries, according to the U.S. Department of Labor. ... many of the injuries. Those injuries often can be ... nursing students at the University of Missouri have a ...
... a hormone disorder that causes a diverse array of ... wasting, and ultimately death. It is caused by a ... the secretion of excess amounts of adrenocorticotropic hormone (ACTH). ... tumors commonly recur, meaning that new treatment options are ...
... (HealthDay News) -- Among older married Americans, an active sex ... with life in general, according to a new study. ... of 238 married people 65 and older who took part ... predicted both overall and marital happiness, and this association remained ...
... use to rate nursing home quality does not provide ... account the degree of cognitive impairment of their patient ... according to a new study. Focusing on statistics ... and the Regenstrief Institute report on the inadequacy of ...
... A patient,s viewpoint of the severity of irritable bowel ... physical symptoms of IBS but broader psychological problems, according ... Hepatology , the official journal of the American Gastroenterological ... in a cost-effective manner within tight time constraints and ...
... 20 (HealthDay News) -- Holiday foods and feasts can ... gastroesophageal reflux disease (GERD), but there are things they ... GERD occurs when a faulty valve between the ... into the esophagus. Symptoms of GERD include heartburn, acid ...
Cached Medicine News:Health News:New safe practices room provides prevention training space for nursing students 2Health News:Regular Sex May Be Key to Happy Marriage for Seniors 2Health News:Nursing home quality scorecards don't tell the whole score 2Health News:Psychological factors affect IBS patients' interpretation of symptom severity 2Health News:Holiday Foods May Trigger GERD Symptoms 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: